Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year EBIT Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -28.58-29.41127.17-8.50468.50

What is the latest EBIT Growth ratio of BAFNA PHARMACEUTICALS ?

The latest EBIT Growth ratio of BAFNA PHARMACEUTICALS is -28.58 based on Mar2025 Standalone results.
Year EBIT Growth
Mar2025-28.58
Mar2024-29.41
Mar2023127.17
Mar2022-8.50
Mar2021468.50

How is EBIT Growth of BAFNA PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 -28.58
Negative
Mar2024 -29.41
Negative
Mar2023 127.17
Positive
Mar2022 -8.5
Negative
Mar2021 468.5 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare EBIT Growth ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹260.2 Cr -4.2% -1.5% 43.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,217.0 Cr 0.9% 6.2% 0.6% Stock Analytics
DIVIS LABORATORIES ₹166,047.0 Cr 1.8% 4.8% 6.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,872.0 Cr 1.3% 9.8% 37.7% Stock Analytics
DR REDDYS LABORATORIES ₹108,454.0 Cr 1.7% 5.8% 6.7% Stock Analytics
CIPLA ₹107,136.0 Cr -1.3% 0.9% -8.9% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-4.2%

-1.5%

43.2%

SENSEX

0%

1.2%

9.7%


You may also like the below Video Courses